Cochrane Abstracts
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Valacyclovir Versus Acyclovir for the Treatment of Herpes Zoster Ophthalmicus in Immunocompetent Patients." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432612/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients.
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432612/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients. Accessed March 16, 2025.
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432612/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients
Valacyclovir Versus Acyclovir for the Treatment of Herpes Zoster Ophthalmicus in Immunocompetent Patients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432612/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients
ID - 432612
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432612/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
